Skip to main content
SpringerLink
Log in

Stroke

  • Chapter
  • First Online:
Neurology

  • 3207 Accesses

Abstract

Our objective, in this evidence-based chapter on stroke, is to present epidemiological, diagnostic, treatment, and prognostic factors for several selected topics in the clinical areas of transient ischemic attack, cardioembolic stroke, acute ischemic stroke, lacunar stroke, and carotid stenosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Johnston SC. Clinical practice. Transient ischemic attack. N Engl J Med. 2002;347:1687–92.

    Article  PubMed  Google Scholar 

  2. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40:2276–93.

    Article  PubMed  Google Scholar 

  3. Levy DE. How transient are transient ischemic attacks? Neurology. 1988;38:674–7.

    PubMed  CAS  Google Scholar 

  4. Pessin MS, Duncan GW, Mohr JP, Poskanzer DC. Clinical and angiographic features of carotid transient ischemic attacks. New Engl J Med. 1977;296:358–62.

    Article  PubMed  CAS  Google Scholar 

  5. Weisberg LA. Clinical characteristics of transient ischemic attacks in black patients. Neurology. 1991;41:1410–4.

    PubMed  CAS  Google Scholar 

  6. Bots ML, van der Wilk EC, Koudstaal PJ, Hofman A, Grobbee DE. Transient neurological attacks in the general population. Prevalence, risk factors, and clinical relevance. Stroke. 1997;28:768–73.

    Article  PubMed  CAS  Google Scholar 

  7. Johnston SC, Nguyen-Huynh MN, Schwarz ME, et al. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol. 2006;60:301–13.

    Article  PubMed  Google Scholar 

  8. Furst G, Saleh A, Wenserski F, et al. Reliability and validity of noninvasive imaging of internal carotid artery pseudo-occlusion. Stroke. 1999;30:1444–9.

    Article  PubMed  CAS  Google Scholar 

  9. Forsting M, Wanke I. Funeral for a friend [comment]. Stroke. 2003;34:1324–32.

    Article  PubMed  Google Scholar 

  10. Nederkoorn PJ, van der Graaf Y, Hunink MG. Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systematic review. Stroke. 2003;34:1324–32.

    Article  PubMed  Google Scholar 

  11. Josephson SA, Bryant SO, Mak HK, Johnston SC, Dillon WP, Smith WS. Evaluation of carotid stenosis using CT angiography in the initial evaluation of stroke and TIA. Neurology. 2004;63:457–60.

    PubMed  CAS  Google Scholar 

  12. Anderson GB, Ashforth R, Steinke DE, Ferdinandy R, Findlay JM. CT angiography for the detection and characterization of carotid artery bifurcation disease. Stroke. 2000;31:2168–74.

    Article  PubMed  CAS  Google Scholar 

  13. Silvennoinen HM, Ikonen S, Soinne L, Railo M, Valanne L. CT angiographic analysis of carotid artery stenosis: comparison of manual assessment, semiautomatic vessel analysis, and digital subtraction angiography. Am J Neuroradiol. 2007;28:97–103.

    Article  PubMed  CAS  Google Scholar 

  14. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901–6.

    Article  PubMed  CAS  Google Scholar 

  15. Nguyen-Huynh MN, Johnston SC. Is hospitalization after TIA cost-effective on the basis of treatment with tPA? Neurology. 2005;65:1799–801.

    Article  PubMed  Google Scholar 

  16. Fallon C, Noone I, Ryan J, O’Shea D, O’Laoide R, Crowe M. Assessment and management of transient ischaemic attack–the role of the TIA clinic. Irish J Med Sci. 2006;175:24–7.

    Article  PubMed  CAS  Google Scholar 

  17. Josephson SA, Sidney S, Pham TN, Bernstein AL, Johnston SC. Higher ABCD2 score predicts patients most likely to have true transient ischemic attack. Stroke. 2008;39:3096–8.

    Article  PubMed  Google Scholar 

  18. Josephson SA, Sidney S, Pham TN, Bernstein AL, Johnston SC. Factors associated with the decision to hospitalize patients after transient ischemic attack before publication of prediction rules. Stroke. 2008;39:411–3.

    Article  PubMed  Google Scholar 

  19. Coben JH, Owens PL, Steiner CA, Crocco TJ. Hospital and demographic influences on the disposition of transient ischemic attack. Acad Emerg Med. 2008;15:171–6.

    Article  PubMed  Google Scholar 

  20. Byrne A, Daly C, Rocke L, Gray J. Can risk stratification of transient ischaemic attacks improve patient care in the emergency department? Emerg Med J. 2007;24:637–40.

    Article  PubMed  Google Scholar 

  21. Bray JE, Coughlan K, Bladin C. Can the ABCD Score be dichotomised to identify high-risk patients with transient ischaemic attack in the emergency department? Emerg Med J. 2007;24:92–5.

    Article  PubMed  Google Scholar 

  22. Nguyen-Huynh MN, Johnston SC. Transient ischemic attack: a neurologic emergency. Curr Neurol Neurosci Rep. 2005;5:13–20.

    Article  PubMed  Google Scholar 

  23. Rothwell PM, Giles MF, Flossmann E, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005;366:29–36.

    Article  PubMed  CAS  Google Scholar 

  24. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369:283–92.

    Article  PubMed  Google Scholar 

  25. Group ES, Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367:1665–73.

    Article  Google Scholar 

  26. Sacco RL, Diener HC, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. New Engl J Med. 2008;359:1238–51.

    Article  PubMed  CAS  Google Scholar 

  27. Kent DM, Thaler DE. Stroke prevention–insights from incoherence. New Engl J Med. 2008;359:1287–9.

    Article  PubMed  CAS  Google Scholar 

  28. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577–617.

    Article  PubMed  Google Scholar 

  29. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P, American College of Chest. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:630S–69.

    Google Scholar 

  30. Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:546S–92.

    Article  PubMed  CAS  Google Scholar 

  31. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:483S–512.

    Article  PubMed  CAS  Google Scholar 

  32. Toth C. The use of a bolus of intravenous heparin while initiating heparin therapy in anticoagulation following transient ischemic attack or stroke does not lead to increased morbidity or mortality. Blood Coagul Fibrinolysis. 2003;14:463–8.

    Article  PubMed  CAS  Google Scholar 

  33. Lengyel M, Vandor L. The role of thrombolysis in the management of left-sided prosthetic valve thrombosis: a study of 85 cases diagnosed by transesophageal echocardiography. J Heart Valve Dis. 2001;10:636–49.

    PubMed  CAS  Google Scholar 

  34. Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest. 2001;119:108S–21.

    Article  PubMed  CAS  Google Scholar 

  35. Morgan MK, Sekhon LH, Finfer S, Grinnell V. Delayed neurological deterioration following resection of arteriovenous malformations of the brain. J Neurosurg. 1999;90:695–701.

    Article  PubMed  CAS  Google Scholar 

  36. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998;29:4–11.

    Article  PubMed  Google Scholar 

  37. Paciaroni M, Agnelli G, Micheli S, Caso V. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke. 2007;38:423–30.

    Article  PubMed  CAS  Google Scholar 

  38. Asinger RW, Dyken ML, Fisher M, Hart RG, Sherman DG. Cardiogenic brain embolism: the second report of Cerebral Embolism Task Force. Arch Neurol. 1989;46:723–43.

    Google Scholar 

  39. Bogousslavsky J, Cachin C, Regli F, Despland PA, Van Melle G, Kappenberger L. Cardiac sources of embolism and cerebral infarction–clinical consequences and vascular concomitants: the Lausanne Stroke Registry. Neurology. 1991;41:855–9.

    PubMed  CAS  Google Scholar 

  40. Caplan L. Posterior circulation ischemia: then, now, and tomorrow. The Thomas Willis Lecture-2000. Stroke. 2000;31:2011–23.

    Article  PubMed  CAS  Google Scholar 

  41. Caplan LR, Wityk RJ, Glass TA, et al. New England Medical Center Posterior Circulation registry. Ann Neurol. 2004;56:389–98.

    Article  PubMed  Google Scholar 

  42. Bogousslavsky J, Regli F, Maeder P, Meuli R, Nader J. The etiology of posterior circulation infarcts: a prospective study using magnetic resonance imaging and magnetic resonance angiography. Neurology. 1993;43:1528–33.

    PubMed  CAS  Google Scholar 

  43. Glass TA, Hennessey PM, Pazdera L, et al. Outcome at 30 days in the New England Medical Center Posterior Circulation Registry [see comment]. Arch Neurol. 2002;59:369–76.

    Article  PubMed  Google Scholar 

  44. Schonewille WJ, Wijman CA, Michel P, Algra A, Kappelle LJ. The Basilar Artery International Cooperative Study (BASICS). Int J Stroke. 2007;2:220.

    Article  PubMed  Google Scholar 

  45. Pessin MS, Lathi ES, Cohen MB, Kwan ES, Hedges 3rd TR, Caplan LR. Clinical features and mechanism of occipital infarction. Ann Neurol. 1987;21:290–9.

    Article  PubMed  CAS  Google Scholar 

  46. Yamamoto Y, Georgiadis AL, Chang HM, Caplan LR. Posterior cerebral artery territory infarcts in the New England Medical Center Posterior Circulation Registry. Arch Neurol. 1999;56:824–32.

    Article  PubMed  CAS  Google Scholar 

  47. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864–70.

    Article  PubMed  CAS  Google Scholar 

  48. Sila CA. Cardioembolic Stroke. In: Noseworthy JH, editor. Neurological Therapeutics: Principles and Practice, vol. 1. London: Martin Dunitz; 2003. p. 450–7.

    Google Scholar 

  49. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. New Engl J Med. 2007;357:2262–8.

    Article  PubMed  CAS  Google Scholar 

  50. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. New Engl J Med. 2001;345:1740–6.

    Article  PubMed  CAS  Google Scholar 

  51. Kizer JR, Devereux RB. Clinical practice. Patent foramen ovale in young adults with unexplained stroke [see comment][erratum appears in N Engl J Med. 2006 Jun 1;354(22):2401]. New Engl J Med. 2005;353:2361–72.

    Article  PubMed  CAS  Google Scholar 

  52. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155:469–73.

    Article  PubMed  CAS  Google Scholar 

  53. Hart RG, Halperin JL. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann Intern Med. 1999;131:688–95.

    PubMed  CAS  Google Scholar 

  54. Hart RG, Halperin JL. Atrial fibrillation and stroke: concepts and controversies. Stroke. 2001;32:803–8.

    Article  PubMed  CAS  Google Scholar 

  55. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest. 2001;119:194S–206.

    Article  PubMed  CAS  Google Scholar 

  56. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol. 1992;20:527–32.

    Article  PubMed  CAS  Google Scholar 

  57. Flaker GC, Fletcher KA, Rothbart RM, Halperin JL, Hart RG. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Am J Cardiol. 1995;76:355–8.

    Article  PubMed  CAS  Google Scholar 

  58. Adams Jr HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115:e478–534.

    Article  PubMed  Google Scholar 

  59. Douglas PS, Khandheria B, Stainback RF, et al. ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine. J Am Coll Cardiol. 2007;50:187–204.

    Article  PubMed  Google Scholar 

  60. Bath PM, Lindenstrom E, Boysen G, et al. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.[see comment][erratum appears in Lancet 2001 Oct 13;358(9289):1276]. Lancet. 2001;358:702–10.

    Article  PubMed  CAS  Google Scholar 

  61. Bruno A, Biller J, Adams Jr HP, et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology. 1999;52:280–4.

    PubMed  CAS  Google Scholar 

  62. Dalal PM, Mishra NK, Bhattacharjee M, Bhat P. Antithrombotic agents in cerebral ischaemia. J Assoc Physicians India. 2006;54:555–61.

    PubMed  CAS  Google Scholar 

  63. Graham SP. To anticoagulate or not to anticoagulate patients with cardiomyopathy. Cardiol Clin. 2001;19:605–15.

    Article  PubMed  CAS  Google Scholar 

  64. Hart RG, Pearce LA, Miller VT, et al. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis. 2000;10:39–43.

    Article  PubMed  CAS  Google Scholar 

  65. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy [see comment]. J Am Coll Cardiol. 2003;42:1066–72.

    Article  PubMed  Google Scholar 

  66. Sandercock P. Full heparin anticoagulation should not be used in acute ischemic stroke. Stroke. 2003;34:231–2.

    Article  PubMed  Google Scholar 

  67. Teitelbaum JS, von Kummer R, Gjesdal K, et al. Effect of ximelagatran and warfarin on stroke subtypes in atrial fibrillation. Can J Neurol Sci. 2008;35:160–5.

    PubMed  Google Scholar 

  68. Yasaka M, Yamaguchi T. Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation. CNS Drugs. 2001;15:623–31.

    Article  PubMed  CAS  Google Scholar 

  69. Anonymous. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators [see comment]. New Engl J Med. 1990;323:1505–11.

    Google Scholar 

  70. Ezekowitz MD, Levine JA. Preventing stroke in patients with atrial fibrillation. JAMA. 1999;281:1830–5.

    Article  PubMed  CAS  Google Scholar 

  71. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989;1:175–9.

    Article  PubMed  CAS  Google Scholar 

  72. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991;18:349–55.

    Article  PubMed  CAS  Google Scholar 

  73. Anonymous. Stroke Prevention in Atrial Fibrillation Study. Final results [see comment]. Circulation 1991;84:527–39.

    Google Scholar 

  74. Pearce LA, Hart RG, Halperin JL. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. Am J Med. 2000;109:45–51.

    Article  PubMed  CAS  Google Scholar 

  75. Anonymous. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials [erratum appears in Arch Intern Med 1994 Oct 10;154(19):2254]. Arch Intern Med. 1994;154:1449–57.

    Google Scholar 

  76. Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest. 1998;114:579S–89.

    Article  PubMed  CAS  Google Scholar 

  77. Anonymous. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators [see comment]. JAMA 1998;279:1273–7.

    Google Scholar 

  78. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–67.

    PubMed  Google Scholar 

  79. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000;356:1648–51.

    Article  PubMed  CAS  Google Scholar 

  80. Maisel WH, Laskey WK. Patent foramen ovale closure devices: moving beyond equipoise. JAMA. 2005;294:366–9.

    Article  PubMed  CAS  Google Scholar 

  81. Messe SR, Silverman IE, Kizer JR, et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology [see comment]. Neurology. 2004;62:1042–50.

    PubMed  CAS  Google Scholar 

  82. Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke [see comment]. New Engl J Med. 1994;331:1474–9.

    Article  PubMed  CAS  Google Scholar 

  83. Fujimoto S, Yasaka M, Otsubo R, Oe H, Nagatsuka K, Minematsu K. Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke. Stroke. 2004;35:1426–9.

    Article  PubMed  Google Scholar 

  84. Tunick PA, Nayar AC, Goodkin GM, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque [see comment]. Am J Cardiol. 2002;90:1320–5.

    Article  PubMed  Google Scholar 

  85. Dressler FA, Craig WR, Castello R, Labovitz AJ. Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke [see comment]. J Am Coll Cardiol. 1998;31:134–8.

    Article  PubMed  CAS  Google Scholar 

  86. Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, et al. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol. 2008;7(9):787–95.

    Article  PubMed  CAS  Google Scholar 

  87. Capampangan DJ et al. Telemedicine versus telephone for remote emergency stroke consultations. A critically appraised topic. Neurologist. 2009;15:163–6.

    Article  PubMed  Google Scholar 

  88. Rosso C et al. Diffusion-weighted MRI in acute stroke within the first 6 hours: 1.5 or 3.0 Tesla. Neurology. 2010;74:1946–53.

    Article  PubMed  CAS  Google Scholar 

  89. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes. Novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol. 2004;61:1066–70.

    Article  PubMed  Google Scholar 

  90. Saver JL. Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Stroke. 2007;38:2279–83.

    Article  PubMed  CAS  Google Scholar 

  91. Gadhia J et al. Assessment and improvement of figures to visually convey benefit and risk of stroke thrombolysis. Stroke. 2010;41:300–6.

    Article  PubMed  Google Scholar 

  92. Saver JL et al. Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window. Joint outcome table analysis of the ECASS trial. Stroke. 2009;40:2433–7.

    Article  PubMed  CAS  Google Scholar 

  93. Norrving B. Lacunar infarcts: no black holes in the brain are benign. Pract Neurol. 2008;8:222–8.

    Article  PubMed  Google Scholar 

  94. Bejot Y, Catteau A, Caillier M, Rouaud O, Durier J, et al. Trends in incidence, risk factors, and survival in symptomatic lacunar stroke in Dijon, France, from 1989 to 2006: a population based study. Stroke. 2008;39:1945–51.

    Article  PubMed  Google Scholar 

  95. Benavente O et al. Small vessel strokes. Curr Cardiol Rep. 2005;7:23–8.

    Article  PubMed  Google Scholar 

  96. Schonewille WJ, Tuhrim S, Singer MB, Atlas SW. Diffusion-weighted MRI in acute lacunar syndromes. A clinical-radiological correlation study. Stroke. 1999;30(10):2066–9.

    Article  PubMed  CAS  Google Scholar 

  97. Arboix A, Marti-Vilalta JL. Lacunar stroke. Expert Rev Neurother. 2009;9(2):179–96.

    Article  PubMed  Google Scholar 

  98. Benavente OR et al. and for the SPS3 Investigators. The secondary prevention of small ­subcortical strokes (SPS3) study. International journal of stroke. 2011;6:164–75. doi: 10.1111/j.1747-4949.2010.00573.x.

    Google Scholar 

  99. Fluri F et al. Intravenous thrombolysis in patients with stroke attributable to small artery occlusion. Eur J Neurol. 2010;17:1054–60.

    Article  PubMed  CAS  Google Scholar 

  100. Jackson C et al. Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain. 2005;128:2507–17.

    Article  PubMed  Google Scholar 

  101. Sacco S et al. A population based study of the incidence and prognosis of lacunar stroke. Neurology. 2006;66:1335–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology Department, Mayo Clinic, 5777 East Mayo Blvd., Phoenix, AZ, 85054, USA

    Maria I. Aguilar MD

  2. Neurology Department, Mayo Clinic, Phoenix, AZ, USA

    Bart M. Demaerschalk MD, MSc, FRCPC

Authors
  1. Maria I. Aguilar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bart M. Demaerschalk MD, MSc, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria I. Aguilar MD .

Editor information

Editors and Affiliations

  1. London Health Sciences Centre, Dept. Clinical Neurosciences, University of Western Ontario, Windermere Road 339, London, N6A 5A5, Ontario, Canada

    Jorge G. Burneo

  2. , Neurology, Mayo Clinic Hospital, E. Mayo Blvd. 5777, Phoenix, 85054, Arizona, USA

    Bart M. Demaerschalk

  3. London Health Sciences Centre, Dept. Clinical Neurosciences, University of Western Ontario, Windermere Road 339, London, N6A 5A5, Ontario, Canada

    Mary E. Jenkins

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Aguilar, M.I., Demaerschalk, B.M. (2012). Stroke. In: Burneo, J., Demaerschalk, B., Jenkins, M. (eds) Neurology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-88555-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-88555-1_4

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-88554-4

  • Online ISBN: 978-0-387-88555-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation